Contract Manufacturing Organization (CMO) Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Contract Manufacturing Organizations (CMO) Market
The Contract Manufacturing Organizations (CMO) market size was valued at USD 145.32 billion in 2023, and the market is now projected to grow from USD 156.29 billion in 2024 to USD 289.68 billion by 2032, exhibiting a CAGR of 8% during the forecast period of 2024-2032.
The worldwide marketplace witnessed a fantastic increase during the COVID-19 pandemic. This boom is credited to growth within the range of COVID-19 instances, which fueled the demand for numerous drugs and increased the want for big-scale production. To fulfil these desires, numerous pharmaceutical and biotechnology businesses partnered with the Contract Manufacturing Organization (CMO), which contributed to the Contract Manufacturing Organizations (CMO) market growth. After the COVID-19 pandemic, the marketplace is ready to enlarge at an ordinary increase rate due to the reduction in the demand for COVID-19-related merchandise, adjustments in capability enlargement plans, and accelerated focus on non-COVID-19 therapeutics.
Over the past few years, the worldwide burden of chronic illnesses, inclusive of diverse cancers, diabetes, and neurological issues, has been growing notably, increasing the demand for biologics and biosimilars. Such a state of affairs is encouraging CMOs to enter the marketplace with their specialised drug manufacturing services. Biologics are complicated molecules that require specialised manufacturing abilities and facilities, prompting several pharmaceutical businesses to associate with settlement manufacturing agencies (CMOs) for his or her manufacturing. This leads to a boost in the Contract Manufacturing Organizations (CMO) market share.
Additionally, the shift closer to digitalised aseptic manufacturing is imparting several advantages over the traditional aseptic manufacturing methods, definitely impacting the complete manufacturing system.
Comprehensive Analysis of Contract Manufacturing Organizations (CMO) Market
The Contract Manufacturing Organizations (CMO) marketplace is segmented with the aid of carriers into API manufacturing, finished product production, and packaging, with completed product manufacturing further divided into solid dosage paperwork, injectables, and others. In 2023, the API manufacturing phase held the biggest market percentage, driven by way of the developing trend of pharmaceutical corporations outsourcing API manufacturing to specialised CMOs for cost-powerful and efficient solutions, mainly in emerging markets. Additionally, the growing worldwide pharmaceutical exports of APIs are expected to enhance production demand, creating full-size possibilities for CMOs and fueling phase increases.
North America ruled the market with a revenue of USD 47.02 billion in 2023. The boom is attributable to the rising demand for powerful and less costly drug production solutions, driven by the want for safer and more powerful capsules, especially advanced treatment options and biologics.
Garrett Motion (Switzerland), Continental GT (Germany), Aptiv PLC (Ireland), Turbonetics (United States), ABB (Switzerland), Cummins Inc. (United States), Ningbo Motor Industrial Co. Ltd. (China), Precision Turbo and Engine Inc. (United States), and Robert Bosch GmbH (Germany) are leading players in the turbocharger market, every contributing to advancements in overall performance, gasoline efficiency, and emission control technology throughout the automobile enterprise.
In April 2024, Lonza collaborated with Acumen Pharmaceuticals, Inc. To manufacture Sabirnetug (ACU193), the first monoclonal antibody for the remedy of Alzheimer’s sickness.
Segmentation Table
Global Contract Manufacturing Organizations (CMO) Market Scope
Study Period 2019-2032
Base Year 2023
Forecast Period 2024-2032
Growth Rate CAGR of 8% from 2024-2032
Historical Period 2019-2022
Unit Value (USD Billion)
Segmentation By service, and Region
By service
API Manufacturing
Finished Product
Solid Dosage Forms
Injectables
Others
Packaging
By Region
North America (By Service and Country)
U.S.
Canada
Europe (By Service and Country/Sub-region)
Germany
U.K.
France
Italy
Spain
Scandinavia
Rest of Europe
Asia Pacific (By Service and Country/Sub-region)
India
China
Japan
Australia
Rest of Asia Pacific
Rest of the World (By Service)Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Technological Advancements in Contract Manufacturing Organizations (CMO) Market
- 4.2. Overview of Regulatory Scenario, By Key Countries/Region
- 4.3. Key Industry Developments Mergers, Acquisitions, Partnerships, etc.
- 4.4. Impact of COVID-19 on the Market
- 5. Global Contract Manufacturing Organizations (CMO) Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast – By Service
- 5.1.1. API Manufacturing
- 5.1.2. Finished Product
- 5.1.2.1. Solid Dosage Forms
- 5.1.2.2. Injectables
- 5.1.2.3. Others
- 5.1.3. Packaging
- 5.2. Market Analysis, Insights and Forecast – By Region
- 5.2.1. North America
- 5.2.2. Europe
- 5.2.3. Asia Pacific
- 5.2.4. Rest of the World
- 6. North America Contract Manufacturing Organizations (CMO) Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast – By Service
- 6.1.1. API Manufacturing
- 6.1.2. Finished Product
- 6.1.2.1. Solid Dosage Forms
- 6.1.2.2. Injectables
- 6.1.2.3. Others
- 6.1.3. Packaging
- 6.2. Market Analysis, Insights and Forecast – By Country
- 6.2.1. U.S.
- 6.2.2. Canada
- 7. Europe Contract Manufacturing Organizations (CMO) Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast – By Service
- 7.1.1. API Manufacturing
- 7.1.2. Finished Product
- 7.1.2.1. Solid Dosage Forms
- 7.1.2.2. Injectables
- 7.1.2.3. Others
- 7.1.3. Packaging
- 7.2. Market Analysis, Insights and Forecast – By Countries/Sub-region
- 7.2.1. Germany
- 7.2.2. France
- 7.2.3. U.K.
- 7.2.4. Italy
- 7.2.5. Spain
- 7.2.6. Scandinavia
- 7.2.7. Rest of the Europe
- 8. Asia Pacific Contract Manufacturing Organizations (CMO) Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast – By Service
- 8.1.1. API Manufacturing
- 8.1.2. Finished Product
- 8.1.2.1. Solid Dosage Forms
- 8.1.2.2. Injectables
- 8.1.2.3. Others
- 8.1.3. Packaging
- 8.2. Market Analysis, Insights and Forecast – By Countries/Sub-region
- 8.2.1. China
- 8.2.2. Japan
- 8.2.3. India
- 8.2.4. Australia
- 8.2.5. Rest of Asia Pacific
- 9. Rest of the World Contract Manufacturing Organizations (CMO) Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast – By Service
- 9.1.1. API Manufacturing
- 9.1.2. Finished Product
- 9.1.2.1. Solid Dosage Forms
- 9.1.2.2. Injectables
- 9.1.2.3. Others
- 9.1.3. Packaging
- 10. Competitive Analysis
- 10.1. Global Market Share Analysis (2023)
- 10.2. Company Profiles (Overview, Services, SWOT analysis, Recent developments, strategies, financials (based on availability))
- 10.2.1. Boehringer Ingelheim International GmbH
- 10.2.1.1. Overview
- 10.2.1.2. Services
- 10.2.1.3. SWOT Analysis
- 10.2.1.4. Recent Developments
- 10.2.1.5. Strategies
- 10.2.1.6. Financials (Based on Availability)
- 10.2.2. Almac Group
- 10.2.2.1. Overview
- 10.2.2.2. Services
- 10.2.2.3. SWOT Analysis
- 10.2.2.4. Recent Developments
- 10.2.2.5. Strategies
- 10.2.2.6. Financials (Based on Availability)
- 10.2.3. Recipharm AB
- 10.2.3.1. Overview
- 10.2.3.2. Services
- 10.2.3.3. SWOT Analysis
- 10.2.3.4. Recent Developments
- 10.2.3.5. Strategies
- 10.2.3.6. Financials (Based on Availability)
- 10.2.4. Dr. Reddy’s Laboratories Ltd.
- 10.2.4.1. Overview
- 10.2.4.2. Services
- 10.2.4.3. SWOT Analysis
- 10.2.4.4. Recent Developments
- 10.2.4.5. Strategies
- 10.2.4.6. Financials (Based on Availability)
- 10.2.5. FAMAR Health Care Services
- 10.2.5.1. Overview
- 10.2.5.2. Services
- 10.2.5.3. SWOT Analysis
- 10.2.5.4. Recent Developments
- 10.2.5.5. Strategies
- 10.2.5.6. Financials (Based on Availability)
- 10.2.6. Lonza
- 10.2.6.1. Overview
- 10.2.6.2. Services
- 10.2.6.3. SWOT Analysis
- 10.2.6.4. Recent Developments
- 10.2.6.5. Strategies
- 10.2.6.6. Financials (Based on Availability)
- 10.2.7. Vetter Pharma-Fertigung GmbH & Co. KG
- 10.2.7.1. Overview
- 10.2.7.2. Services
- 10.2.7.3. SWOT Analysis
- 10.2.7.4. Recent Developments
- 10.2.7.5. Strategies
- 10.2.7.6. Financials (Based on Availability)
- 10.2.8. Jubilant Pharmova Limited
- 10.2.8.1. Overview
- 10.2.8.2. Services
- 10.2.8.3. SWOT Analysis
- 10.2.8.4. Recent Developments
- 10.2.8.5. Strategies
- 10.2.8.6. Financials (Based on Availability)
- 10.2.9. Catalent Inc.
- 10.2.9.1. Overview
- 10.2.9.2. Services
- 10.2.9.3. SWOT Analysis
- 10.2.9.4. Recent Developments
- 10.2.9.5. Strategies
- 10.2.9.6. Financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook